Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients

被引:94
|
作者
Miyazaki, Y
Pipek, R
Mandarino, LJ
DeFronzo, RA
机构
[1] Univ Texas, Hlth Sci Ctr, Diabet Div, San Antonio, TX 78229 USA
[2] Texas Diabet Inst, San Antonio, TX USA
关键词
type; 2; diabetes; tumor necrosis factor alpha; insulin sensitivity;
D O I
10.1038/sj.ijo.0802187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between basal serum tumor necrosis factor alpha (TNFalpha) levels and peripheral tissue (muscle) sensitivity to insulin was examined in 63 subjects with normal glucose tolerance (NGT), 18 subjects with impaired glucose tolerance (IGT), and 123 patients with type 2 diabetes mellitus (T2DM). The BMI was similar in NGT (28.8 +/- 0.7 kg/m(2)), IGT (31.1 +/- 1.0), and T2DM (30.0 +/- 0.4) groups. The fasting serum TNFalpha concentration in T2DM (4.4 +/- 0.2 pg/ml) was significantly higher than in NGT (3.1 +/- 0.2) and IGT (3.4 +/- 0.2; both P < 0.05). In T2DM the fasting plasma glucose (PPG 183 +/- 5 mg/dl) and insulin (FPI = 17 +/- 1 μU/ml) concentrations were significantly higher than in NGT (FPG = 95 +/- 1; FPI = 10 +/- 1) and IGT (FPG = 100 +/- 2; FPI = 13 +/- 1; all P < 0.01). The rate of total body insulin-mediated glucose disposal (Rd; 40 mU/m(2) min euglycemic insulin clamp in combination with H-3-glucose) was reduced in T2DM (102 +/- 3 mg/m(2) min) compared with NGT (177 10) and IGT (151 +/- 14; both P<0.01). The serum TNFα concentration was inversely correlated with Rd (r=-0.47, P<0.0001) and positively correlated with both FPG (r=0.32, P=0.004) and FPI (r=0.32, P=0.004) in NGT plus IGT. No correlation was observed between serum TNFalpha and Rd (r= -0.02), FPG (r= 0.15), or FPI (r= 0.15) in T2DM. In stepwise multiple regression analysis using age, sex, BMI, FPG, FPI and serum TNFalpha concentration as independent variables, only BMI and serum TNFalpha concentration were significant and independent predictors of Rd (r(2) = 0.29, P < 0.0001) in the NGT plus IGT group, while FPG and FPI were significant and independent predictors of Rd (r(2) = 0.13, P < 0.0001) in T2DM. These results suggest that: (i) an increase in circulating TNFalpha concentration is associated with peripheral insulin resistance and increased plasma glucose and insulin levels prior to the onset of type 2 diabetes; and (ii) the further deterioration in peripheral insulin resistance in T2DM (compared with NGT and IGT) is unrelated to the increase in serum TNFalpha concentration.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 50 条
  • [31] Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1 -: Response -: Contribution of tumor necrosis factor-α in insulin resistance in patients with android type obesity
    Winkler, G
    Lakatos, P
    Salamon, F
    Speer, G
    Baranyi, É
    Melczer, Z
    Cseh, K
    DIABETES CARE, 1999, 22 (05) : 870 - 870
  • [32] Study of Serum Tumor Necrosis Factor Alpha and Interleukin 6 in Type 2 Diabetic Patients with Albuminuria
    Zahran, Ahmed
    Essa, Enas S.
    Abd Elazeem, Waleed F.
    LIFE SCIENCE JOURNAL-ACTA ZHENGZHOU UNIVERSITY OVERSEAS EDITION, 2012, 9 (01): : 877 - 882
  • [33] Discriminant Model for Insulin Resistance in Type 2 Diabetic Patients
    Lopez-Galan, Erislandis
    Barrio-Deler, Rafael
    Fernandez-Fernandez, Manuel Alejandro
    Del Toro-Delgado, Yaquelin
    Penuela-Puente, Isaac Enrique
    Sanchez-Hechavarria, Miguel Enrique
    Munoz-Bustos, Mario Eugenio
    Munoz-Bustos, Gustavo Alejandro
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [34] Exenatide or Glimepiride on Insulin Resistance in Type 2 Diabetic Patients
    Derosa, Giuseppe
    Putignano, Pietro
    Bossi, Antonio C.
    Bianchi, Lucio
    Querci, Fabrizio
    Franzetti, Ivano G.
    Guazzini, Barbara
    Testori, Giampaolo
    Fogari, Elena
    Maffioli, Pamela
    DIABETES, 2011, 60 : A294 - A294
  • [35] Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea
    Chang, SA
    Kim, HS
    Yoon, KH
    Ko, SH
    Kwon, HS
    Kim, SR
    Lee, WC
    Yoo, SJ
    Son, HS
    Cha, BY
    Lee, KW
    Son, HY
    Kang, SK
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (02): : 142 - 146
  • [36] Quantitative insulin sensitivity check index as a novel clinical index of insulin resistance in non-obese and obese type2 diabetic patients
    Yokoyama, H
    Emoto, M
    Komatsu, M
    Tanaka, A
    Morioka, T
    Koyama, H
    Shoji, T
    Okuno, Y
    Inaba, M
    Nishizawa, Y
    DIABETES, 2002, 51 : A479 - A480
  • [37] Metabolic and vascular effects of tumor necrosis factor-α blockade with etanercept in obese patients with type 2 diabetes
    Dominguez, H
    Storgaard, H
    Rask-Madsen, C
    Hermann, TS
    Ihlemann, N
    Nielsen, DB
    Spohr, C
    Kober, L
    Vaag, A
    Torp-Pedersen, C
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 (06) : 517 - 525
  • [38] Tumor necrosis factor system in insulin resistance in gestational diabetes
    Winkler, G
    Cseh, K
    Baranyi, É
    Melczer, Z
    Speer, G
    Hajós, P
    Salamon, F
    Turi, Z
    Kovács, M
    Vargha, P
    Karádi, I
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (02) : 93 - 99
  • [39] Tumor necrosis factor-α-induced insulin resistance in adipocytes
    Qi, C
    Pekala, PH
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (02): : 128 - 135
  • [40] Tumor necrosis factor-α and insulin resistance in essential hypertension
    Ashcheulova, T
    JOURNAL OF HYPERTENSION, 2002, 20 : S63 - S63